Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in latin america

Pediatric Infectious Disease Journal

Volumn 30, Issue 6, 2011, Pages

  Tregnaghi, Miguel W ^a   Abate, Héctor J ^b   Valencia, Alejandra ^c   Lopez, Pio ^d   Da Silveira, Themis Reverbel ^e   Rivera, Luis ^e   Rivera Medina, Doris Maribel ^f,g,h   Saez Llorens, Xavier ⁱ   Gonzalez Ayala, Silvia Elena ^j,k   De León, Tirza ^l   Van Doorn, Leen Jan ^m   Pilar Rubio, Maria Del ⁿ   Suryakiran, Pemmaraju Venkata ^o   Casellas, Javier M ⁿ   Ortega Barria, Eduardo ⁿ   Smolenov, Igor V ^p   Han, Htay Htay ^q  

^a Centro de Desarrollo de Proyectos Avanzados Cordoba   (Argentina)

^b Hospital Pediatrico Dr Humberto Notti   (Argentina)

^c Fundación Santa Fe Carrera Novena N   (Colombia)

^d UNIVERSIDAD DEL VALLE   (Colombia)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^f Perinatology   (Dominican Republic)

^g Hospital de Especialidades   (Honduras)

^h Clinical Research Department   (Honduras)

ⁱ Hospital del Niño   (Panama)

^j FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^k Hospital de Ninos Sor Maria Ludovica   (Argentina)

^l Hospital José Domingo de Obaldía   (Panama)

^m GSK   (Italy)

ⁿ DDL Diagnostic Laboratory   (Netherlands)

^o GlaxoSmithKline Pharmaceuticals Ltd   (India)

^p GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^q GLAXOSMITHKLINE   (United States)

more..

Author keywords

Efficacy; Latin America; OPV; Rotavirus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN A; PLACEBO; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; BRONCHIOLITIS; DIPHTHERIA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GASTROENTERITIS; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFLUENZA; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PERTUSSIS; PHASE 3 CLINICAL TRIAL; PNEUMONIA; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS INFECTION; SOUTH AND CENTRAL AMERICA; TETANUS;

EID: 79958000903     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182138278     Document Type: Article

References (27)

1. WHO position paper. Wkly Epidemiol Rec. 2007;82:285-296.
2. Parashar UD, Hummelmann EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis J. 2003;9:565-572.
3. Linhares AC, Bresee JS. Rotavirus vaccines and vaccination in Latin America. Rev Panam Salud Publica. 2000;8:305-331.
4. Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022-1028.
5. Grimwood K, Lambert SB. Rotavirus vaccines: opportunities and challenges. Hum Vaccin. 2009;5:57-69.
6. Clark HF, Offit PA, Glass RI, et al. Rotavirus vaccines. In: Plotkin S, Orenstein W. Vaccines. 4th ed. New York: Elsevier Inc; 2004:1327. Chap 51.
7. Bernstein DI, Smith VE, Sherwood JR, et al. Safety and immunogenicity of a live attenuated human rotavirus 89-12 vaccine. Vaccine. 1998;16:381-387.
8. Bernstein DI, Sack DA, Rothstein E, et al. Efficacy of live attenuated human rotavirus vaccine 89-12 in infants. Lancet. 1999;354:287-290.
9. Bernstein DI, Sack DA, Reisinger K, et al. Second-year follow-up evaluation of live attenuated human rotavirus vaccine 89-12 in healthy infants. J Infect Dis. 2002;186:1487-1489.
10. Linhares AC, Velázquez FR, Schael IP, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomized, double-blind, placebo-controlled phase III study. Lancet. 2008;371:1181-1189.
11. Vesikari T, Karvonen A, Korhonen T, et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine. 2004;22:2836-2842.
12. Salinas B, Schael IP, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24:807-816.
13. Ruiz-Palacios GM, Schael IP, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
14. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-1763.
15. Phua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomized, double-blind, controlled study. Vaccine. 2009;27:5936-5941.
16. Phua KB, Emmanuel SC, Goh P, et al. A rotavirus vaccine for infants: the Asian experience. Ann Acad Med. 2006;35:38-44.
17. Vodopija I, Baklaic Z, Vlatkovic R, et al. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine. 1986;4:233-236.
18. Migasena S, Simasathien S, Samakoses R, et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral polio vaccine (OPV) in Thai infants. Vaccine. 1995;13:168-174.
19. Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine. 2010;28:6542-6548.
20. WHO. The treatment of diarrhea. A manual for physicians and other senior health workers. Department of child and adolescent health and development. Available at: http://whqlibdoc.who.int/hq/2003/WHO_FCH_CAH_03.7.pdf. Accessed September 7, 2010.
21. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for severity of diarrheal episodes. Scand J Infect Dis. 1990;22:259-267.
22. van Doorn LJ, Kleter B, Hoefnagel E, et al. Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization. J Clin Microbiol. 2009;47:2704-2712.
23. Ward RL, Bernstein DI, Shukla R, et al. Effects of antibodies to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis. 1989;159:79-88.
24. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in the Gambia, Oman and Thailand. Bull World Health Organ. 1996;74:253-268.
25. Bernstein DI. Rotavirus overview. Pediatr Infect Dis J. 2009;28:S50-S53.
26. Castello AA, Arvay ML, Glass RI, et al. Rotavirus strain surveillance in Latin America a review of the last nine years. Pediatr Infect Dis J. 2004;23:S168-S172.
27. The State of the World's Children 2009. United Nations Children's Fund-UNICEF. Available at: http://data.un.org/Data.aspx?q=Latin+America&d=SOWC&f=inID%3a18%3bcrID%3a186%2c5. Accessed September 7, 2010.